Vascular endothelial cells as immunological targets in atheroscleroisis

Inflammation and Atherosclerosis

Volumn 9783709103388, Issue , 2012, Pages 87-114

  Fogal, Birgit ^a   Pober, Jordan S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930698269     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0338-8_6     Document Type: Chapter

References (241)

1. Arnout J, Hoylaerts MF, Lijnen HR (2006) Haemostasis. Handb Exp Pharmacol 176(Pt 2):1-41
2. Bazzoni G, Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84(3):869-901
3. Busse R, Fleming I (2006) Vascular endothelium and blood flow. Handb Exp Pharmacol 176(Pt 2):43-78
4. Ley K, Reutershan J (2006) Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol 176(Pt 2):97-133
5. Minshall RD, Malik AB (2006) Transport across the endothelium: regulation of endothelial permeability. Handb Exp Pharmacol 176(Pt 1):107-144
6. Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508-519
7. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK (1985) Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 76 (1):125-131
8. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6(2):131-138
9. Kovanen PT, Kaartinen M, Paavonen T (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92(5):1084-1088
10. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340(2):115-126
11. Weber C, Zernecke A, Libby P (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8(10):802-815
12. Frank PG, Pavlides S, Lisanti MP (2009) Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res 335(1):41-47
13. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86(1):279-367
14. Pries AR, Secomb TW, Gaehtgens P (2000) The endothelial surface layer. Pflugers Arch 440(5):653-666
15. Davies PF, Civelek M, Fang Y, Guerraty MA, Passerini AG (2010) Endothelial heterogeneity associated with regional athero-susceptibility and adaptation to disturbed blood flow in vivo. Semin Thromb Hemost 36(3):265-275
16. Davies PF (2009) Hemodynamic shear stress and the endothelium in cardiovascular patho-physiology. Nat Clin Pract Cardiovasc Med 6(1):16-26
17. Bogatcheva NV, Garcia JG, Verin AD (2002) Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc) 67(1):75-84
18. Clark PR, Manes TD, Pober JS, Kluger MS (2007) Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J Invest Dermatol 127(4):762-774
19. Hamik A, Jain MK (2010) Shear stress: devil's in the details. Blood 116(15):2625-2626
20. Pober JS, Min W, Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4:71-95
21. Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY (2004) Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 25(5):371-376
22. Gao Y, Liu C, Zhang X, Gao J, Yang C (2008) Circulating endothelial cells as potential markers of atherosclerosis. Can J Neurol Sci 35(5):638-642
23. von Eckardstein A, Rohrer L (2009) Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr Opin Lipidol 20(3):197-205
24. Minshall RD, Tiruppathi C, Vogel SM, Malik AB (2002) Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 117(2): 105-112
25. Gratton JP, Bernatchez P, Sessa WC (2004) Caveolae and caveolins in the cardiovascular system. Circ Res 94(11):1408-1417
26. Frank PG, Woodman SE, Park DS, Lisanti MP (2003) Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 23(7):1161-1168
27. Anderson RG (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225
28. Stan RV, Roberts WG, Predescu D, Ihida K, Saucan L, Ghitescu L et al (1997) Immunoi-solation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Mol Biol Cell 8(4):595-605
29. Frank PG, Pavlides S, Cheung MW, Daumer K, Lisanti MP (2008) Role of caveolin-1 in the regulation of lipoprotein metabolism. Am J Physiol Cell Physiol 295(1):C242-C248
30. Sun SW, Zu XY, Tuo QH, Chen LX, Lei XY, Li K et al (2010) Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol Sin 31(10):1336-1342
31. Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116(16): 1832-1844
32. Schwenke DC, Carew TE (1989) Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 9(6):908-918
33. Buga GM, Gold ME, Fukuto JM, Ignarro LJ (1991) Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17(2):187-193
34. Davis ME, Cai H, Drummond GR, Harrison DG (2001) Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 89(11):1073-1080
35. Davis ME, Grumbach IM, Fukai T, Cutchins A, Harrison DG (2004) Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J Biol Chem 279(1):163-168
36. Furchgott RF (1999) Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep 19(4):235-251
37. Moncada S (1994) Nitric oxide. J Hypertens Suppl 12(10):S35-S39
38. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43(2):109-142
39. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88(11):4651-4655
40. Yates MT, Lambert LE, Whitten JP, McDonald I, Mano M, Ku G et al (1992) A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett 309(2):135-138
41. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S (1993) Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334(2):170-174
42. Malo-Ranta U, Yla-Herttuala S, Metsa-Ketela T, Jaakkola O, Moilanen E, Vuorinen P et al (1994) Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett 337(2):179-183
43. Cardona-Sanclemente LE, Born GV (1995) Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat. Br J Pharmacol 114 (7):1490-1494
44. Won D, Zhu SN, Chen M, Teichert AM, Fish JE, Matouk CC et al (2007) Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow. Am J Pathol 171(5):1691-1704
45. Jessup W, Mohr D, Gieseg SP, Dean RT, Stocker R (1992) The participation of nitric oxide in cell free-and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta 1180(1):73-82
46. Kaur K, Salomon RG, O'Neil J, Hoff HF (1997) (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem Res Toxicol 10(12):1387-1396
47. Suarna C, Dean RT, May J, Stocker R (1995) Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 15(10):1616-1624
48. Hoppe G, Ravandi A, Herrera D, Kuksis A, Hoff HF (1997) Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J Lipid Res 38(7):1347-1360
49. Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA (1999) Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and In vivo inhibition by WEB 2086. Circ Res 85(4):311-318
50. Kuhn H, Heydeck D, Hugou I, Gniwotta C (1997) In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99(5):888-893
51. Boulanger C, Luscher TF (1990) Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85(2):587-590
52. Luscher TF, Yang Z, Tschudi M, von Segesser L, Stulz P, Boulanger C et al (1990) Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 66(4):1088-1094
53. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM (2001) Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 104(8):864-869
54. Ivey ME, Osman N, Little PJ (2008) Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis 199(2): 237-247
55. Ruschitzka F, Moehrlen U, Quaschning T, Lachat M, Noll G, Shaw S et al (2000) Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease. Circulation 102(10):1086-1092
56. Celebi H, Catakoglu AB, Kurtoglu H, Sener M, Hanavdelogullari R, Demiroglu C et al (2008) The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Cardiovasc Revasc Med 9(3):144-148
57. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325(14):997-1001
58. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J (2005) Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 145(3):323-333
59. Wedgwood S, Black SM (2005) Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288(3):L480-L487
60. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr et al (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96(1):60-68
61. Maus U, Henning S, Wenschuh H, Mayer K, Seeger W, Lohmeyer J (2002) Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow. Am J Physiol Heart Circ Physiol 283(6):H2584-H2591
62. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J (2006) Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 26(5):1002-1007
63. Goligorsky MS, Patschan D, Kuo MC (2009) Weibel-Palade bodies-sentinels of acute stress. Nat Rev Nephrol 5(7):423-426
64. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C et al (2003) Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115(2):139-150
65. Qian Z, Gelzer-Bell R, Yang Sx SX, Cao W, Ohnishi T, Wasowska BA et al (2001) Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection. Circulation 104(19):2369-2375
66. Stassen JM, Arnout J, Deckmyn H (2004) The hemostatic system. Curr Med Chem 11(17): 2245-2260
67. Esmon NL, Carroll RC, Esmon CT (1983) Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 258(20):12238-12242
68. Herschman HR (1999) Function and regulation of prostaglandin synthase 2. Adv Exp Med Biol 469:3-8
69. Topper JN, Cai J, Falb D, Gimbrone MA Jr (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93(19):10417-10422
70. Walshe TE, Ferguson G, Connell P, O'Brien C, Cahill PA (2005) Pulsatile flow increases the expression of eNOS, ET-1, and prostacyclin in a novel in vitro coculture model of the retinal vasculature. Invest Ophthalmol Vis Sci 46(1):375-382
71. Radomski MW, Palmer RM, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2(8567):1057-1058
72. Wang W, Diamond SL (1997) Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 233(3):748-751
73. Galbusera M, Zoja C, Donadelli R, Paris S, Morigi M, Benigni A et al (1997) Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. Blood 90(4):1558-1564
74. Colburn P, Buonassisi V (1982) Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycans. Biochem Biophys Res Commun 104(1):220-227
75. Shimada K, Kobayashi M, Kimura S, Nishinaga M, Takeuchi K, Ozawa T (1991) Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface. Jpn Circ J 55(10): 1016-1021
76. Benedict CR, Pakala R, Willerson JT (1994) Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding. Tex Heart Inst J 21(1):86-90
77. Emeis JJ (1992) Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci 667:249-258
78. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G (2000) Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902:230-239
79. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G (1998) Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 139 (2):205-222
80. Kume N, Cybulsky MI, Gimbrone MA Jr (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90(3):1138-1144
81. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL et al (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272(21):13597-13607
82. Leitinger N (2003) Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14(5):421-430
83. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR (2006) Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 45(6):466-486
84. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73(1):205-209
85. Goodwin BL, Pendleton LC, Levy MM, Solomonson LP, Eichler DC (2007) Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. Am J Physiol Heart Circ Physiol 293(2):H1115-H1121
86. Seidel M, Billert H, Kurpisz M (2006) Regulation of eNOS expression in HCAEC cell line treated with opioids and proinflammatory cytokines. Kardiol Pol 64(2):153-158
87. Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM et al (2006) Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99(1):69-77
88. Xia Z, Liu M, Wu Y, Sharma V, Luo T, Ouyang J et al (2006) N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. Eur J Pharmacol 550(1-3):134-142
89. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD (2003) The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 28(5):574-581
90. Pan J, Xia L, McEver RP (1998) Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J Biol Chem 273(16):10058-10067
91. Munro JM, Pober JS, Cotran RS (1989) Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 135(1):121-133
92. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H et al (2005) Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180(1):11-17
93. Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27(11):2292-2301
94. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M et al (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10):1255-1262
95. Jongstra-Bilen J, Haidari M, Zhu SN, Chen M, Guha D, Cybulsky MI (2006) Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 203(9):2073-2083
96. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86(2):515-581
97. Santiago B, Baleux F, Palao G, Gutierrez-Canas I, Ramirez JC, Arenzana-Seisdedos F et al (2006) CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans. Arthritis Res Ther 8(2):R43
98. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184(3): 1101-1109
99. Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, Gardner K et al (2005) Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105(10):3910-3917
100. Yu G, Rux AH, Ma P, Bdeir K, Sachais BS (2005) Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 105(9):3545-3551
101. Schwartz SM, Benditt EP (1977) Aortic endothelial cell replication. I. Effects of age and hypertension in the rat. Circ Res 41(2):248-255
102. Li JH, Pober JS (2005) The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. J Immunol 175(3):1858-1866
103. Doukas J, Pober JS (1990) IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J Immunol 145(6):1727-1733
104. Li JH, Kluger MS, Madge LA, Zheng L, Bothwell AL, Pober JS (2002) Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol 161(4):1485-1495
105. Kreuz S, Siegmund D, Scheurich P, Wajant H (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21(12): 3964-3973
106. Schwartz SM, Stemerman MB, Benditt EP (1975) The aortic intima. II. Repair of the aortic lining after mechanical denudation. Am J Pathol 81(1):15-42
107. Fujikawa LS, Wickham MG, Binder PS (1980) Wound healing in cultured corneal endothe-lial cells. Invest Ophthalmol Vis Sci 19(7):793-801
108. Yoder MC (2010) Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol 30(6):1094-1103
109. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J et al (2009) Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116(3):219-230
110. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Saemann M et al (2007) Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and gluco-corticoid therapy. Ann Rheum Dis 66(10):1284-1288
111. Nilsson J, Hansson GK (2008) Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med 263(5):464-478
112. Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22:361-403
113. Lamb DJ, El-Sankary W, Ferns GA (2003) Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 167(2):177-185
114. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG et al (2003) Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 23(6):1060-1065
115. Foteinos G, Xu Q (2009) Immune-mediated mechanisms of endothelial damage in atherosclerosis. Autoimmunity 42(7):627-633
116. Xu Q, Wick G (1996) The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 2(9):372-379
117. Seitz CS, Kleindienst R, Xu Q, Wick G (1996) Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab Invest 74(1):241-252
118. Xu Q, SchettG, Seitz CS, Hu Y, Gupta RS, WickG (1994) Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 75(6):1078-1085
119. Amberger A, Maczek C, Jurgens G, Michaelis D, Schett G, Trieb K et al (1997) Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 2(2):94-103
120. Pfister G, Stroh CM, Perschinka H, Kind M, Knoflach M, Hinterdorfer P et al (2005) Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci 118(Pt 8):1587-1594
121. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G et al (1992) Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12(7):789-799
122. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G (1993) Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest 91(6):2693-2702
123. Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ, Gaston JS (2000) T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol 121(2):261-269
124. Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M et al (2003) Cardiovascular risk factors and atherosclerosis in young males: ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 108(9):1064-9
125. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW et al (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86(4):1372-1376
126. Palinski W, Witztum JL (2000) Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 247(3):371-380
127. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92(9):3893-3897
128. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J (1992) Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 12(4):461-467
129. Hermansson A, Ketelhuth DF, Strodthoff D, Wurm M, Hansson EM, Nicoletti A et al (2010) Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med 207(5):1081-1093
130. Zhou X, Robertson AK, Hjerpe C, Hansson GK (2006) Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 26(4):864-870
131. Shiao SL, McNiff JM, Pober JS (2005) Memory T cells and their costimulators in human allograft injury. J Immunol 175(8):4886-4896
132. Shiao SL, Kirkiles-Smith NC, Shepherd BR, McNiff JM, Carr EJ, Pober JS (2007) Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol 179(7):4397-4404
133. Hart DN, Fuggle SV, Williams KA, Fabre JW, Ting A, Morris PJ (1981) Localization of HLA-ABC and DR antigens in human kidney. Transplantation 31(6):428-433
134. Hancock WW, Kraft N, Atkins RC (1982) The immunohistochemical demonstration of major histocompatibility antigens in the human kidney using monoclonal antibodies. Pathology 14(4):409-414
135. Manes TD, Pober JS (2008) Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells. J Immunol 180(12):8386-8392
136. Manes TD, Pober JS, Kluger MS (2006) Endothelial cell-T lymphocyte interactions: IP [corrected]-10 stimulates rapid transendothelial migration of human effort but not central memory CD4+ T cells. Requirements for shear stress and adhesion molecules. Transplantation 82(1 Suppl):S9-S14
137. Choi JH, Do Y, Cheong C, Koh H, Boscardin SB, Oh YS et al (2009) Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 206(3): 497-505
138. Biedermann BC, Pober JS (1999) Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J Immunol 162(12):7022-7030
139. Dengler TJ, Pober JS (2000) Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 164(10):5146-5155
140. Xu Q, Kiechl S, Mayr M, Metzler B, Egger G, Oberhollenzer F et al (1999) Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100(11):1169-1174
141. Xiao Q, Mandal K, Schett G, Mayr M, Wick G, Oberhollenzer F et al (2005) Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 36(12):2571-2576
142. Schett G, Xu Q, Amberger A, van der Zee R, Recheis H, Willeit J et al (1995) Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 96(6):2569-2577
143. Schett G, Metzler B, Mayr M, Amberger A, Niederwieser D, Gupta RS et al (1997) Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 128(1):27-38
144. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, Cameron SJ, Bao C, Fox-Talbot K et al (2007) Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci USA 104(4):1301-1306
145. Lucchiari N, Panajotopoulos N, Xu C, Rodrigues H, Ianhez LE, Kalil J et al (2000) Antibodies eluted from acutely rejected renal allografts bind to and activate human endo-thelial cells. Hum Immunol 61(5):518-527
146. Hosenpud JD, Shipley GD, Morris TE, Hefeneider SH, Wagner CR (1993) The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies. Transplantation 55(2):405-411
147. Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Horkko S et al (2005) The role of natural antibodies in atherogenesis. J Lipid Res 46(7):1353-1363
148. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C et al (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57(2):287-293
149. Lockshin MD, Salmon JE, Roman MJ (2001) Atherosclerosis and lupus: a work in progress. Arthritis Rheum 44(10):2215-2217
150. Bruce IN, Burns RJ, Gladman DD, Urowitz MB (2000) Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol 27(10): 2372-2377
151. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N et al (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112(21):3337-3347
152. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J 10(1):3-7
153. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690-1697
154. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121(10 Suppl 1):S21-S31
155. Manzi S, Wasko MC (2000) Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59(5):321-325
156. Pasceri V, Yeh ET (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100(21):2124-2126
157. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104(16):1887-1893
158. Asanuma Y, Chung CP, Oeser A, Shintani A, Stanley E, Raggi P et al (2006) Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 33(3):539-545
159. Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108(24): 2957-2963
160. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR et al (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45(7):1169-1196
161. Maziere C, Auclair M, Maziere JC (1994) Tumor necrosis factor enhances low density lipopro-tein oxidative modification by monocytes and endothelial cells. FEBS Lett 338(1):43-46
162. Lee YH, Choi SJ, Ji JD, Seo HS, Song GG (2000) Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 19(4):324-325
163. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D et al (2005) Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111(2):204-211
164. Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y (2008) Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 75(2):131-137
165. McLaren JE, Ramji DP (2009) Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 20(2):125-135
166. Luster AD, Unkeless JC, Ravetch JV (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315(6021):672-676
167. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U et al (1997) P-and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385(6611):81-83
168. Chaplin DD (2002) Cell cooperation in development of eosinophil-predominant inflammation in airways. Immunol Res 26(1-3):55-62
169. Bennett BL, Cruz R, Lacson RG, Manning AM (1997) Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. J Biol Chem 272(15):10212-10219
170. Thornhill MH, Haskard DO (1990) IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol 145(3):865-872
171. Masinovsky B, Urdal D, Gallatin WM (1990) IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 145(9):2886-2895
172. Blease K, Seybold J, Adcock IM, Hellewell PG, Burke-Gaffney A (1998) Interleukin-4 and lipopolysaccharide synergize to induce vascular cell adhesion molecule-1 expression in human lung microvascular endothelial cells. Am J Respir Cell Mol Biol 18(5):620-630
173. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T et al (2008) The complex role of T-cell-based immunity in atherosclerosis. Curr Atheroscler Rep 10(3): 236-243
174. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W et al (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114(3):427-437
175. Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL et al (2009) Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 206(11):2407-2416
176. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (∗). Annu Rev Immunol 28:445-489
177. Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4 + CD25+ T cell-mediated suppression by dendritic cells. Science 299(5609):1033-1036
178. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal MR, Roncarolo MG (2001) IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166(9):5530-5539
179. Warner SJ, Auger KR, Libby P (1987) Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol 139(6):1911-1917
180. Rao DA, Tracey KJ, Pober JS (2007) IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. J Immunol 179(10):6536-6546
181. Dienz O, Rincon M (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130(1): 27-33
182. Nishimoto N, Kishimoto T (2006) Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2(11):619-626
183. Rochman I, Paul WE, Ben-Sasson SZ (2005) IL-6 increases primed cell expansion and survival. J Immunol 174(8):4761-4767
184. McLoughlin RM, Jenkins BJ, Grail D, Williams AS, Fielding CA, Parker CR et al (2005) IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci USA 102(27):9589-9594
185. Vardam TD, Zhou L, Appenheimer MM, Chen Q, Wang WC, Baumann H et al (2007) Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance. Cytokine 39(1):84-96
186. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235-238
187. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517
188. Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C et al (2009) IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113(18):4240-4249
189. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112(6):2340-2352
190. Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G et al (2008) IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 105(47):18460-18465
191. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT et al (2008) The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 127(1):89-97
192. Xie JJ, Wang J, Tang TT, Chen J, Gao XL, Yuan J et al (2010) The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 49(2):185-193
193. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, Idu MM, van Maldegem F et al (2010) Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol 220(4):499-508
194. Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F et al (2009) Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 183(12): 8167-8175
195. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K et al (2010) Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121(15):1746-1755
196. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A et al (2009) Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119(10):1424-1432
197. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86(2):515-81
198. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R et al (2001) Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89(10):930-934
199. Biedermann BC, Pober JS (1998) Human endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol 161(9):4679-4687
200. Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K et al (2010) Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 107(33):14733-14738
201. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ et al (2002) T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105(5): 570-575
202. Li JH, Kirkiles-Smith NC, McNiff JM, Pober JS (2003) TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells. J Immunol 171(3):1526-1533
203. Bai Y, Ahmad U, Wang Y, Li JH, Choy JC, Kim RW et al (2008) Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation. J Biol Chem 283(11): 6832-6842
204. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25(10):2054-2061
205. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK et al (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349(24):2316-2325
206. Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310(3):175-177
207. Khurana R, Simons M, Martin JF, Zachary IC (2005) Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112(12):1813-1824
208. Khurana R, Zhuang Z, Bhardwaj S, Murakami M, De Muinick E, Yla-Herttuala S et al (2004) Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110(16): 2436-2443
209. Langheinrich AC, Michniewicz A, Bohle RM, Ritman EL (2007) Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE/LDL double knockout mice. Atherosclerosis 191(1):73-81
210. Langheinrich AC, Sedding DG, Kampschulte M, Moritz R, Wilhelm J, Haberbosch WG et al (2009) 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice. Atherosclerosis 202(1):103-110
211. Galkina E, Ley K (2009) Immune and inflammatory mechanisms of atherosclerosis (∗). Annu Rev Immunol 27:165-197
212. Kaartinen M, Penttila A, Kovanen PT (1994) Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90(4):1669-1678
213. Costa C, Incio J, Soares R (2007) Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10(3):149-166
214. Rafii DC, Psaila B, Butler J, Jin DK, Lyden D (2008) Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler Thromb Vasc Biol 28(2):217-222
215. Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Leseche G, Devue C et al (2008) CD40 ligand + microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 52(16):1302-1311
216. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E et al (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100(8):4736-4741
217. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J (1999) Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99(13):1726-1732
218. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y et al (2005) Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol 36(4):330-340
219. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P (2004) Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24(7):1309-1314
220. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158(3):879-891
221. Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94(1): 437-444
222. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T et al (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108(12):1440-1445
223. Brennan ML, Penn MS, Van LF, Nambi V, Shishehbor MH, Aviles RJ et al (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349(17):1595-1604
224. Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG et al (2007) Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 50(2):159-165
225. Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J et al (1999) Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 274(17):11924-11929
226. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P (1995) Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 748:501-507
227. Amento EP, Ehsani N, Palmer H, Libby P (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11(5):1223-1230
228. Davies MJ (1996) Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94(8):2013-2020
229. Grignani G, Maiolo A (2000) Cytokines and hemostasis. Haematologica 85(9):967-972
230. Bombeli T, Karsan A, Tait JF, Harlan JM (1997) Apoptotic vascular endothelial cells become procoagulant. Blood 89(7):2429-2442
231. Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG et al (2003) Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 23(3):440-446
232. Levy AP, Moreno PR (2006) Intraplaque hemorrhage. Curr Mol Med 6(5):479-488
233. Schwartz CJ, Mitchell JR (1962) Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation 26:73-78
234. Higuchi ML, Gutierrez PS, Bezerra HG, Palomino SA, Aiello VD, Silvestre JM et al (2002) Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Arq Bras Cardiol 79(1):20-24
235. Watanabe M, Sangawa A, Sasaki Y, Yamashita M, Tanaka-Shintani M, Shintaku M et al (2007) Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J Atheroscler Thromb 14(6):325-331
236. Wilcox JN, Scott NA (1996) Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 54(Suppl):S21-S35
237. Cowan DB, Langille BL (1996) Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol 7(2):94-100
238. Zhou J, Tang PC, Qin L, Gayed PM, Li W, Skokos EA et al (2010) CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med 207(9):1951-1966
239. Herity NA, Ward MR, Lo S, Yeung AC (1999) Review: clinical aspects of vascular remodeling. J Cardiovasc Electrophysiol 10(7):1016-1024
240. Pasterkamp G, Borst C, Post MJ, Mali WP, Wensing PJ, Gussenhoven EJ et al (1996) Atherosclerotic arterial remodeling in the superficial femoral artery. Individual variation in local compensatory enlargement response. Circulation 93(10):1818-1825
241. Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB (1997) Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation 95(7):1791-1798